Chapin Davis, Inc. Haleon PLC Transaction History

Chapin Davis, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$8.02 - $8.67 $481 - $520	-60 Reduced 0.4%	15,087 $128 Million
Q4 2023 Jan 11, 2024	SELL	$7.78 - $8.62 $2,956 - $3,275	-380 Reduced 2.45%	15,147 $125 Million
Q3 2023 Oct 19, 2023	SELL	$7.85 - $8.94 $9,380 - $10,683	-1,195 Reduced 7.15%	15,527 $129 Million
Q2 2023 Aug 30, 2023	BUY	$8.04 - $9.0 $3,818 - $4,275	475 Added 2.92%	16,722 $140 Million
Q1 2023 Apr 12, 2023	SELL	$7.57 - $8.37 $14,042 - $15,526	-1,855 Reduced 10.25%	16,247 $132 Million
Q4 2022 Jan 27, 2023	BUY	$5.96 - $8.06 $107,887 - $145,902	18,102 New	18,102 $145 Million

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Chapin Davis, Inc., based on Form 13F filings with the SEC.

Stay updated on Chapin Davis, Inc. with notifications on news.